Prestige Consumer Healthcare (PBH) Current Assets (2011 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Current Assets of $433.4 million for Q4 2025, up 14.92% year-over-year from $377.2 million in Q4 2024, and down 12.86% quarter-over-quarter from $497.4 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Current Assets (2011 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Current Assets history runs 15 years deep, the most recent figure standing at $433.4 million for Q4 2025.
- In Q4 2025, Current Assets rose 14.92% year-over-year to $433.4 million; the TTM figure through Dec 2025 stood at $433.4 million (up 14.92% YoY), while the FY2025 annual figure was $448.3 million, up 19.54% from the prior year.
- Current Assets for Q4 2025 stood at $433.4 million, down from $497.4 million in the prior quarter.
- The five-year high for Current Assets was $497.4 million in Q3 2025, with the low at $269.8 million in Q1 2021.
- The 5-year median for Current Assets is $384.5 million (2023), against an average of $377.4 million.
- The sharpest annual moves came in 2021 and 2022: Current Assets declined 26.2% in 2021, then soared 48.53% in 2022.
- Prestige Consumer Healthcare's Current Assets stood at $275.3 million in 2021, then jumped by 48.53% to $408.8 million in 2022, then decreased by 3.68% to $393.8 million in 2023, then dropped by 4.22% to $377.2 million in 2024, then gained by 14.92% to $433.4 million in 2025.
- Business Quant data shows PBH's Current Assets at $433.4 million in Q4 2025, $497.4 million in Q3 2025, and $480.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.22 Bn |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | - | 431.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 431.48 Mn |
| Dec 31, 2025 | 433.43 Mn |
| Sep 30, 2025 | 497.41 Mn |
| Jun 30, 2025 | 480.52 Mn |
| Mar 31, 2025 | 448.33 Mn |
| Dec 31, 2024 | 377.16 Mn |
| Sep 30, 2024 | 380.71 Mn |
| Jun 30, 2024 | 368.74 Mn |
| Mar 31, 2024 | 375.04 Mn |
| Dec 31, 2023 | 393.79 Mn |
| Sep 30, 2023 | 388.20 Mn |
| Jun 30, 2023 | 391.76 Mn |
| Mar 31, 2023 | 391.74 Mn |
| Dec 31, 2022 | 408.85 Mn |
| Sep 30, 2022 | 336.65 Mn |
| Jun 30, 2022 | 324.62 Mn |
| Mar 31, 2022 | 293.27 Mn |
| Dec 31, 2021 | 275.27 Mn |
| Sep 30, 2021 | 304.81 Mn |
| Jun 30, 2021 | 408.52 Mn |